I know how you feel. It is clear that Peregrine is skating over some very thin ice. We do need a serious partner and FDA approval for the 2nd Line NSCLC Phase III trial. Monday would not be too soon.
Serious good news from the front line NSCLC trial would also help. It would have to be bullet proof, because we all know there are folks out there who just love to torpedo Peregrine.
A really big settlement with CSM would help as well, but I'll just have to see it to believe it.
Meanwhile we are like a pinata at a really big birthday party.
It's so discouraging reading this board sometimes. Always the "next" trial that will ge us a deal or make the pps move. A little too much hope on the board right now for 1st line. And every time someone mentions breakthrough, I cringe. If what the company has told us to date is true, there is enough out there for a deal.
How about a loan? SOMETHING. Anything to show someone else other than management and Ihub believes in Bavi. Starting to feel like I own a bunch of Avid shares.
Great and truthful post! First line trial is not double binded. The data is known. The fact that we can't even get a loan is telling. Remember even mgmt put their foot in their mouth by saying that Oxford would have no problem doing another loan. So what's the problem?
Sombering fact is we waited for over a year for the FDA to approve a Cotara phase 3 trail that mgmt agreed upon and insisted upon but yet after another three months there is still no partner. Where are the partners they were talking with when they were waiting for the FDA decision? The supposed partners knew exactly what the trial would be if approved and the data. My opinion is there will never be a big deal of Cotara as it would have happened already. As always with this mgmt team it is the mgmt who cried we are in talks. All imo.
News 
Market Data 
Discover 
